These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 6610539
1. Influence of spontaneous and inducible beta-lactamase production on the antimicrobial activity of recently developed beta-lactam compounds. Cullmann W, Opferkuch W, Stieglitz M, Dick W. Chemotherapy; 1984; 30(3):175-81. PubMed ID: 6610539 [Abstract] [Full Text] [Related]
2. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae. Binfiglio G, Stefani S, Nicoletti G. Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454 [Abstract] [Full Text] [Related]
3. [Induction of beta-lactamases in Enterobacter cloacae with beta-lactam antibiotics]. Cullmann W, Dick W. Immun Infekt; 1984 Feb; 12(1):29-34. PubMed ID: 6335880 [Abstract] [Full Text] [Related]
4. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E. Acta Med Croatica; 2004 Feb; 58(4):307-12. PubMed ID: 15700687 [Abstract] [Full Text] [Related]
5. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins. Jarlier V, Nicolas MH, Philippon A, Giroir AM, Grosset J. J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939 [Abstract] [Full Text] [Related]
6. Evidence for nonspecific induction of beta-lactamase in overproducing variants of Enterobacter cloacae and Citrobacter freundii. Cullmann W, Dick W. Eur J Clin Microbiol; 1985 Feb; 4(1):34-40. PubMed ID: 3872794 [Abstract] [Full Text] [Related]
7. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients. Costopoulos C, Legakis NJ, Papafragas E, Marinis E. Chemotherapy; 1984 Feb; 30(3):158-64. PubMed ID: 6610538 [Abstract] [Full Text] [Related]
8. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae. Cullmann W, Flensberg T, Opferkuch W, Stieglitz M, Wiedemann B. Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):480-9. PubMed ID: 6758422 [Abstract] [Full Text] [Related]
9. Frequency and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae isolates susceptible to third-generation cephalosporins or to aztreonam. Bert F, Bialek-Davenet S, Leflon-Guibout V, Noussair L, Nicolas-Chanoine MH. Med Mal Infect; 2014 Feb; 44(2):76-8. PubMed ID: 24525113 [Abstract] [Full Text] [Related]
10. Relationship between beta-lactamases production and resistance to beta-lactam antibiotics in clinical isolates of Enterobacteriaceae. Romero E, Pagani L, Perduca M, Mignatti P, Malfa S, Mills V. Microbiologica; 1984 Jul; 7(3):209-18. PubMed ID: 6334220 [Abstract] [Full Text] [Related]
13. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes. Mushtaq S, Warner M, Ge Y, Kaniga K, Livermore DM. J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456 [Abstract] [Full Text] [Related]
16. Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review. Mizrahi A, Delerue T, Morel H, Le Monnier A, Carbonnelle E, Pilmis B, Zahar JR, on behalf the Saint-Joseph/Avicenna Study Group. Int J Antimicrob Agents; 2020 Feb; 55(2):105834. PubMed ID: 31682902 [Abstract] [Full Text] [Related]